resveratrol has been researched along with Rhabdomyosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cruz, AS; Magalhães, VD; Okazaki, K; Rogero, JR; Rogero, SO; Vieira, DP | 1 |
| Gu, Z; Ji, Y; Jiang, J; Li, Y; Shi, M; Shi, W; Sun, J; Wang, Y; Xu, X; Zhang, L | 1 |
| Boddie, AW; Chow, AW; Das Gupta, TK; Mehta, RG; Murillo, G; Pezzuto, JM; van Breemen, RB; Yu, C | 1 |
3 other study(ies) available for resveratrol and Rhabdomyosarcoma
| Article | Year |
|---|---|
In vitro tests of resveratrol radiomodifying effect on rhabdomyosarcoma cells by comet assay.
Topics: Cell Line, Tumor; Cell Survival; Comet Assay; Cytoprotection; Dose-Response Relationship, Radiation; Gamma Rays; Humans; Radiation-Sensitizing Agents; Resveratrol; Rhabdomyosarcoma; Stilbenes | 2014 |
Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway.
Topics: Antiviral Agents; Cytokines; Dose-Response Relationship, Drug; Enterovirus A, Human; Glucosides; I-kappa B Kinase; Inflammation; Interleukin-6; NF-kappa B; Phosphorylation; Resveratrol; Rhabdomyosarcoma; Signal Transduction; Stilbenes; Tumor Necrosis Factor-alpha; Virus Replication | 2015 |
Resveratrol inhibits rhabdomyosarcoma cell proliferation.
Topics: Anticarcinogenic Agents; Biopsy, Needle; Blotting, Western; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunohistochemistry; Resveratrol; Rhabdomyosarcoma; Risk Factors; Sensitivity and Specificity; Stilbenes; Tumor Cells, Cultured | 2005 |